Ledger.Open graph →
SEC Form D · filed February 19, 2016

Tarsa Therapeutics, Inc

Offering
$2.0M
Sold
$2.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PHILADELPHIA, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (19)

David Brand · Philadelphia, PAExec · DirectorMartin Edwards · Philadelphia, PADirectorEric Bednarski · Waltham, MADirectorJames Tananbaum · Philadelphia, PADirectorDeanna Derrick · George Town, Grand Cayman, Cayman IslandsDirectorTheodore Marmor · NEW YORK, NYExec · DirectorKamran Moghtaderi · New York, NYDirectorRichard Kollender · Philadelphia, PADirectorGregory Lumpkin · Philadelphia, PAExecDerek Ferguson · Los Angeles, CADirectorLewis Geffen · Boston, MAExecStephen G. Hosmer · El Cajon, CAExec · DirectorDonald G. Hosmer · El Cajon, CADirectorNicholas D. Russell · Greenwich, CTDirectorRichard Kollender · Philadelphia, PADirectorGregory Lumpkin · Philadelphia, PAExecDerek Ferguson · Philadelphia, PADirectorLewis Geffen · BOSTON, MAExecJames Tananbaum · Fort Washington, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗